207 related articles for article (PubMed ID: 16483704)
1. Data considerations for regulation of water contaminants.
Schoeny R; Haber L; Dourson M
Toxicology; 2006 Apr; 221(2-3):217-24. PubMed ID: 16483704
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
3. Use of genetic toxicology information for risk assessment.
Dearfield KL; Moore MM
Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
[TBL] [Abstract][Full Text] [Related]
4. IPCS framework for analyzing the relevance of a noncancer mode of action for humans.
Boobis AR; Doe JE; Heinrich-Hirsch B; Meek ME; Munn S; Ruchirawat M; Schlatter J; Seed J; Vickers C
Crit Rev Toxicol; 2008; 38(2):87-96. PubMed ID: 18259981
[TBL] [Abstract][Full Text] [Related]
5. Deriving uncertainty factors for threshold chemical contaminants in drinking water.
Ritter L; Totman C; Krishnan K; Carrier R; Vézina A; Morisset V
J Toxicol Environ Health B Crit Rev; 2007 Oct; 10(7):527-57. PubMed ID: 17934949
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
7. IPCS framework for analyzing the relevance of a cancer mode of action for humans.
Boobis AR; Cohen SM; Dellarco V; McGregor D; Meek ME; Vickers C; Willcocks D; Farland W
Crit Rev Toxicol; 2006; 36(10):781-92. PubMed ID: 17118728
[TBL] [Abstract][Full Text] [Related]
8. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
Butterworth BE
Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
[TBL] [Abstract][Full Text] [Related]
9. Reconciling science and policy in setting federal drinking water standards--four states' perspectives.
Hutcheson MS; Dupuy CJ; Matyas B; McGeorge L; Vanderslice R
Regul Toxicol Pharmacol; 1995 Aug; 22(1):11-23. PubMed ID: 7494897
[TBL] [Abstract][Full Text] [Related]
10. Mode of action in relevance of rodent liver tumors to human cancer risk.
Holsapple MP; Pitot HC; Cohen SM; Boobis AR; Klaunig JE; Pastoor T; Dellarco VL; Dragan YP
Toxicol Sci; 2006 Jan; 89(1):51-6. PubMed ID: 16221960
[TBL] [Abstract][Full Text] [Related]
11. Role of detection limits in drinking water regulation.
Calder RS; Schmitt KA
Environ Sci Technol; 2010 Nov; 44(21):8008-14. PubMed ID: 20925425
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk assessment: importance of identifying mechanisms of action.
Bull RJ
J Am Water Works Assoc; 1990 Oct; 82(10):57-60. PubMed ID: 11538297
[TBL] [Abstract][Full Text] [Related]
13. Comparison of noncancer risk assessment approaches for use in deriving drinking water criteria.
Gibson MC; deMonsabert SM; Orme-Zavaleta J
Regul Toxicol Pharmacol; 1997 Dec; 26(3):243-56. PubMed ID: 9441915
[TBL] [Abstract][Full Text] [Related]
14. Combining occurrence and toxicity information to identify priorities for drinking-water mixture research.
Ryker SJ; Small MJ
Risk Anal; 2008 Jun; 28(3):653-66. PubMed ID: 18643823
[TBL] [Abstract][Full Text] [Related]
15. Drinking water and women's health.
Afzal BM
J Midwifery Womens Health; 2006; 51(1):12-8. PubMed ID: 16399605
[TBL] [Abstract][Full Text] [Related]
16. Health risk assessment of drinking water contaminants in Canada: the applicability of mixture risk assessment methods.
Krishnan K; Paterson J; Williams DT
Regul Toxicol Pharmacol; 1997 Oct; 26(2):179-87. PubMed ID: 9356281
[TBL] [Abstract][Full Text] [Related]
17. Health-based screening levels to evaluate U.S. Geological Survey ground water quality data.
Toccalino PL; Norman JE
Risk Anal; 2006 Oct; 26(5):1339-48. PubMed ID: 17054535
[TBL] [Abstract][Full Text] [Related]
18. Incorporating biologically based models into assessments of risk from chemical contaminants.
Bull RJ; Conolly RB; De Marini DM; MacPhail RC; Ohanian EV; Swenberg JA
J Am Water Works Assoc; 1993 Mar; 85(3):49-52. PubMed ID: 11538064
[TBL] [Abstract][Full Text] [Related]
19. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
[TBL] [Abstract][Full Text] [Related]
20. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
Bogen KT
Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
